Marmarelis ME, Sun L, Aggarwal C. Adjuvant Atezolizumab Should Be Administered to All Patients With Programmed
Death-Ligand 1 Expressing Surgically Resected Stage II to III NSCLC After
Chemotherapy: In Favor. J Thorac Oncol 2023;18:265-267.
PMID: 36842810